USGS Science⌕ Search

Geology topics

K. Coffin

Publications and source records attributed to K. Coffin.

2 recordsLinked to original sources

Efficacy of single calfhood vaccination of elk with Brucella abortus strain 19

Brucellosis has been eradicated from cattle in the states of Wyoming, Montana, and Idaho, USA. However, free-ranging elk (Cervus elaphus) that use feedgrounds in the Greater Yellowstone Area (GYA) and bison (Bison bison) in Yellowstone and Grand Teton national parks still have high seroprevalence to the disease and have caused loss of brucellosis-free status in Wyoming. Management tools to control or eliminate the disease are limited; however, wildlife vaccination is among the methods currently used by wildlife managers in Wyoming. We conducted a controlled challenge study of single calfhood vaccination. Elk calves, caught in January and February of 1999 and 2000 and acclimated to captivity for 3 weeks, were randomly assigned to control or vaccinate groups. The vaccinate groups received Brucetta abortus vaccine strain 19 (S19) by hand-delivered intramuscular injection. Calves were raised to adulthood and bred at either 2.5 or 3.5 years of age for 2000 and 1999 captures, respectively. Eighty-nine (44 controls, 45 vaccinates) pregnant elk entered the challenge portion of the study. We challenged elk at mid-gestation with pathogenic B. abortus strain 2308 by intraconjunctival instillation. Abortion occurred in significantly more (P = 0.002) controls (42; 93%) than vaccinates (32; 71%), and vaccine protected 25% of the vaccinate group. We used Brucella culture of fetus/calf tissues to determine the efficacy of vaccination for preventing infection, and we found that the number of infected fetuses/calves did not differ between controls and vaccinates (P = 0.14). Based on these data, single calfhood vaccination with S19 has low efficacy, will likely have only little to moderate effect on Brucella prevalence in elk, and is unlikely to eradicate the disease in wildlife of the GYA.

Journal of Wildlife Management↗

Survival and immobilizing moose with carfentanil and xylazine

The use of carfentanil with other drugs to immobilize moose (Alces alces) has yielded mixed results. Previous work on chemically immobilizing moose with these drugs reported mortality of 6–19%. Even the most recent study of free-ranging moose using the same drug combination as we used in this report (carfentanil and xylazine) had 6% mortality within several days of immobilization. Another recent study suggested that carfentanilxylazine produced unsatisfactory results in moose through exacerbated mortality risks induced by xylazine. As part of an ongoing study of carnivore effects on moose populations, we chemically immobilized 48 moose (41 adult females, one immature male, 6 calves) by charge-powered dart. Low-stress techniques were used, including quiet ground stalks by one individual and use of blindfolds and low noise during processing. On our few aerial captures we immediately withdrew the helicopter once the dart was placed and landed during induction. We found that capture-related mortality can be minimized by using effective immobilization dosages that maintain sternal recumbency, by providing naltrexone by intramuscular and subcutaneous routes, by effectively antagonizing xylazine, and by using low-stress techniques. Female moose survival was diminished when body condition was below a threshold, and some mortality occurred, likely due to poor condition per se and not as a direct result of immobilization. We provide a field protocol and drug doses that wildlife managers can use to safely immobilize moose.

Wildlife Society Bulletin↗